S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
CGC   15.33 (-3.22%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
CGC   15.33 (-3.22%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
CGC   15.33 (-3.22%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
CGC   15.33 (-3.22%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
T   39.50 (+1.41%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
BAC   32.93 (+0.70%)
DIS   144.67 (-1.69%)
Log in

Preveceutical Medical Stock Price, Forecast & Analysis (CNSX:PREV)

Today's Range N/A
50-Day Range
$0.04
MA: $0.04
$0.05
52-Week Range N/A
Volume12,025 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
PreveCeutical Medical Inc., a health sciences company, develops options for preventive and curative therapies utilizing organic and nature identical products. It has research and development programs, including dual gene therapy for curative and prevention therapies for diabetes and obesity; the Program; Nature Identical peptides for treatment of various ailments; non-addictive analgesic peptides as a replacement to the addictive analgesics, such as morphine, fentanyl, and oxycodone; and a therapeutic product for treating athletes who suffer from concussions. The company offers CELLB9 immune system booster, an oral solution containing polarized and potentiated essential minerals extracted from a peptide obtained from Caribbean blue scorpion venom. It also provides medicinal cannabis-based products. The company has a research and option agreement with University of Queensland; and the UniQuest Pty Limited to develop non-addictive analgesics for the treatment of pain. It also has a strategic research and development supply agreement with Aurora Cannabis to produce medical cannabis. PreveCeutical Medical Inc. is based in Vancouver, Canada.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone604-416-7777

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive PREV News and Ratings via Email

Sign-up to receive the latest news and ratings for PREV and its competitors with MarketBeat's FREE daily newsletter.


Preveceutical Medical (CNSX:PREV) Frequently Asked Questions

What is Preveceutical Medical's stock symbol?

Preveceutical Medical trades on the CNSX under the ticker symbol "PREV."

Has Preveceutical Medical been receiving favorable news coverage?

Media stories about PREV stock have trended somewhat negative on Friday, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Preveceutical Medical earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View News Stories for Preveceutical Medical.

Who are some of Preveceutical Medical's key competitors?

What other stocks do shareholders of Preveceutical Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Preveceutical Medical investors own include Valens GroWorks (VGW), Equinix (EQIX), Aurora Cannabis (ACB), Canopy Growth (WEED), AcelRx Pharmaceuticals (ACRX), OrganiGram (OGI), Supreme Cannabis (FIRE), EnWave (ENW), Engagement Labs (EL) and Quinsam Capital (QCA).

Who are Preveceutical Medical's key executives?

Preveceutical Medical's management team includes the folowing people:
  • Mr. Stephen Van Deventer, Chairman & CEO (Age 50)
  • Dr. Makarand Jawadekar Ph.D., Chief Science Officer, Pres & Director (Age 68)
  • Ms. Shabira Rajan CPA, CGA, CFO & Controller (Age 63)
  • Ms. Deanna Kress, Director of Corp. Communications & Investor Relations
  • Ms. Alicia Rebman, Marketing Director (Age 42)

How do I buy shares of Preveceutical Medical?

Shares of PREV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Preveceutical Medical's official website?

The official website for Preveceutical Medical is http://www.preveceutical.com/.

How can I contact Preveceutical Medical?

The company can be reached via phone at 604-416-7777.


MarketBeat Community Rating for Preveceutical Medical (CNSX PREV)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  18 (Vote Outperform)
Underperform Votes:  9 (Vote Underperform)
Total Votes:  27
MarketBeat's community ratings are surveys of what our community members think about Preveceutical Medical and other stocks. Vote "Outperform" if you believe PREV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PREV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel